Gainers Watch List: Onyx Pharmaceuticals, Unum Group, PulteGroup, Inc. (NYSE:PHM), Opko Health Inc

Lakeway, NY -- (SBWIRE) -- 03/05/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) increased 2.54% and closed at $77.16. Onyx Pharmaceuticals, Inc. will host an Analyst Day on March 14, 2013 from 8:30 a.m. to 11:30 a.m. ET. During this meeting, members of the Onyx leadership team will review commercial and development progress and physician experts will share their perspectives.

How Should Investors Trade ONXX After The Recent Price movement? Find out Here

Unum Group (NYSE:UNM) was up 2.48% and closed at $25.22. Fitch Ratings has affirmed Unum Group Inc.'s holding company ratings at 'BBB' as well as the Insurer Financial Strength ratings of all domestic operating subsidiaries at 'A'. The Rating Outlook is Stable. Unum Group is a provider of disability insurance products in the United States and the United Kingdom. The Company also provides a portfolio of other insurance products, including employer- and employee-paid group benefits, life insurance, and other related services.

Is UNM a Strong Buying Opportunity After The Recent Slump? Find out Here

PulteGroup, Inc. (NYSE:PHM) soared 2.44% and closed at $19.72. The Company will present at the Raymond James & Associates' 34th Annual Institutional Investors Conference on March 5, 2013. The Company based in Bloomfield Hills, Mich., is one of America's largest homebuilding companies with operations in approximately 60 markets throughout the country.

Is PHM a Buy After The Latest Price Action? Find Out Here

Opko Health Inc. (NYSE:OPK) moved up 2.43% and closed at $7.16. The Company has completed the acquisition of Cytochroma Inc. Cytochroma's lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis.

Get latest News, Updates on OPK Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.